Skip to content

Ionis Pharmaceuticals Inc.

IONS Nasdaq SEC CIK 874015

Follow Ionis Pharmaceuticals Weekly email: filings, results, news

News

6 stories filed under Ionis Pharmaceuticals, grouped into ongoing threads

Alexander disease

Thread · 2 stories

Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval and Launch Strategy for ZANVASTRO in Alexander Disease - Slideshow

Markets 16 d ago

Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval and Launch Strategy for ZANVASTRO in Alexander Disease Transcript

Markets 20 d ago

More coverage

Ionis Pharmaceuticals Shares Fall After Pelacarsen Phase 3 Trial Misses Primary Endpoint

Markets 14 d ago 4 sources

BMO cuts Ionis Pharmaceuticals stock price target on drug failure

Markets 16 d ago 2 sources also on BMO

Here's Why Ionis Pharmaceuticals' Steep Sell-off Was Overdone

Markets 21 d ago

Could Ionis Pharmaceuticals (IONS) Stock Become a Biotech Powerhouse as its Commercial Pipeline Takes Off?

Markets 26 d ago

Next results

OCT28

Q2 2026 results

Wednesday · estimated from the filing cadence

Profile

Headquarters: CARLSBAD, CA, United States
Sector: Healthcare
Industry: Pharmaceutical Preparations

Peers

Where this page comes from

Profile · SEC EDGAR

Next results · estimated from the filing cadence (SEC EDGAR)

News · 6 stories clustered from the RSS aggregator